What's The BUZZ?

Market News, Products, Services, and Trends

Equashield’s State-of-the-Art Manufacturing Complex Fulfilling Customer Orders at Record Pace

Global Supply Chain Challenges Still Exist, but are Neutralized by CSTD Leader’s Machine Learning-based Manufacturing Efficiencies


Equashield_1.jpg
Equashield Compounding Technologies Campus


PORT WASHINGTON, N.Y., Aug. 25, 2022 /PRNewswire/ — Equashield, a leading provider of closed system transfer devices (CSTDs) for hazardous drugs, today announced that its state-of-the-art, automated manufacturing facility is offering the company the ability to fulfill large quantity customer orders on-time, effectively neutralizing the global shortage and supply chain challenges that are plaguing delivery across industry.


“Our expectation of significant growth led us several years ago to develop a manufacturing facility that would be truly revolutionary in the CSTD space,” said Marino Kriheli, Co-founder of Equashield. “While we had no idea of the challenges the COVID era would bring, our insistence on building for the future has paid off dramatically over the past two years for nurses and pharmacists alike.”


Equashield_2.jpg
Equashield Compounding Technologies implemented Industry 4.0 manufacturing technology,
leading the CSTD manufacturing landscape


Equashield implemented proprietary machine learning and artificial intelligence (AI) to its quality control and manufacturing lines in its 112,000 square foot manufacturing facility that includes a 20,000-square foot cleanroom space. Production is fully automated, from material entry to robot-managed packaging and palletizing, preserving the sterility of products while maintaining quality efficiency of manufacturing.


This facility, as well as a strong distribution arm in New York, now enables the company to build months of inventory to support increasing market demands with impeccable quality assurance and quick supply fulfillment worldwide.


“Our world-class facility efficiently meets growing market demands and hazardous drug compounding and administration solutions,” said Jason Dutcher, Equashield LLC Director of Strategic Accounts. “We pride ourselves on the ability to deliver safe exposure prevention to those who work with and around hazardous drugs.”


The Equashield CSTD provides unparalleled safety and ease of use for healthcare workers handling hazardous drugs. Key features include an integrated pressure equalization system within the sealed syringe barrel, a dry disconnection mechanism to prevent leaks, and Equashield’s proprietary closed syringe back and metal plunger rod to mitigate contamination and escape of hazardous drugs from the syringe back and plunger. Equashield’s CSTD portfolio includes a wide range of sealed-back syringes and adaptors that can accommodate any drug vial, along with a selection of connectors and tubing sets compatible with all IV infusion bags.

Equashield

Equashield News & Announcements

At EQUASHIELD® our mission is to provide superior solutions for the protection of healthcare workers worldwide. Our state of the art devices are carefully designed, easy to use, and reduce the risk of hazardous drug exposure.

10-rxinsider-staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

This post is related to:

SUBSCRIBE

Please enable JavaScript in your browser to complete this form.
Name
Subscription Choices
Checkboxes

Request information from Equashield’s State-of-the-Art Manufacturing Complex Fulfilling Customer Orders at Record Pace

Please enable JavaScript in your browser to complete this form.
Name
Address
Subscribe